Neuro part 2 classes Flashcards

1
Q

Alpha & Beta adrenergic agonists MEDS and prototype

A
  • Epinephrine (adrenalin): shock, glaucoma, prolongs effects of regional anesthetic
  • Norepinephrine (Levophed) : tx shock or during cardiac arrest to get sympathetic activity
  • Dopamine: shock
  • Dobutamine: congestive heart failure
  • Ephedrine: seasonal rhinitis, hypotensive episodes

PROTOTYPE: DOPAMINE
Ectopic beats

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

MOA of Alpha & Beta adrenergic agonists

A

Effects mediated by receptors in target organs
HR increases
Bronchi dilate, RR increases
Blood vessels constrict, BP increases
IOP decreases, pupils dilate
Glycogenolysis occurs
Sweating occurs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Indications and CI of alpha and beta agonists

A

Indications:
Hypotension, hypotensive shock
Bronchospasm, asthma

Ci:
Pheochromocytoma
Tachyarrhythmia, v fib
Hypovolemia
Peripheral vascular disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

AE and DDI alpha and beta agonists

A

AE:
Cardiac – htn arrhythmia, palpitation, angina
Resp – dyspnea
GI – n/v/c
CNS – h/a, sweating, tension, piloerection
Labs - hypokalemia

DDI:
TCAs, MAOIs
HTN causing meds, OTCs, herbals

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Alpha selective adrenergic agonists MEDS and prototype

A
  • Clonidine (catapres): essential htsn, chronic pain, opiate w/d
  • Dexmedetomidine (precedex): sedation of intubated/ ventilated clients
  • Guanfacine (intuniv): ADHD
  • Midodrine (orvaten): otho hypotension
  • Phenylephrine: cold/allx, preoperative, hypotsn, CVT, glaucoma, OM, vasodilatory shock

PROTOTYPE: Phenylephrine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

MOA and CI to Alpha selective adrenergic agonists

A

MOA:
Stimulate alpha receptors

CI:
Severe HTN
Narrow angle glaucoma
Hypotension, bradycardia
CV disease, vasomotor spasm
Thyrotoxicosis, DM
Renal / Hepatic impairment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

AE and DDI to alpha selective agonists

A

AE:
Cardiac – arrhythmia, BP changes, PV problems
GI – n/v, anorexia
GU – decreased UOP, sexual dysfunction
CNS – anxiety, restlessness, fatigue, depression, blurred vision, sensitivity to light

DDI:
TCAs, MAOIs
CNS depressants
Antihypertensives
Digoxin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Nursing implications to alpha selective agonists

A

taper for d/c (2-4 days), monitor GI, UOP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Beta selective adrenergic agonists
MEDS and prototype

A

Albuterol: bronchospasm
Levalbuterol (Xopenex): asthma, bronchospasm
Isoproterenol: Treatment of shock, cardiac standstill, prevention of bronchospasm during anesthesia. Reserved for emergencies due to adverse effects. Short duration = not generally used for tx. Of asthma
Metaproterenol: asthma, bronchospasm
Salmeterol (serevent diskus): asthma, bronchospasm, COPD
Terbutaline: asthma, bronchospasm

PROTOTYPE: Isoproterenol
Monitor pulmonary, thyroid, cv, cns

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

MOA and indications of beta selective agonists

A

MOA:
Stimulate beta receptors
Increase heart rate, conductivity, and contractility, bronchodilation, blood flow to skeletal muscles, and relaxation of uterus

Indications:
Bronchospasm

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

CI to beta selective agonists

A
  • Pulm HTN, tachyarrhythmia, angina, DM, thyroid dz, vasomotor dz, CVA
  • Eclampsia/uterine hemorrhage/IU death
  • Pregnancy
  • Renal / Hepatic impairment
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

AE to beta selective agonists

A

Cardiac – tachycardia, angina, MI, palpitations
Resp – SOB, cough, bronchospasm, pulm edema
GI – n/v, anorexia
Labs - hypokalemia
CNS – anxiety, restlessness, fatigue, fear, tremor, h/a, sweating, pupil dilation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

DDI to beta selective agonists

A

Sympathomimetics
Beta-adrenergic blockers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Nonselective adrenergic blockers
MEDS and prototype

A
  • Amiodarone (cordarone): ventricular arrhythmia, afib
  • Carvedilol (coreg): Hypertension, congestive heart failure (adult), Left ventricular dysfunction after MI
  • Labetalol (normodyne, trandate): Hypertension, HTN assoc. with pheochromocytoma, clonidine withdrawal

PROTOTYPE: Labetalol
Gastric pain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

MOA and indications of Nonselective adrenergic blockers

A

MOA:
- Competitively block the effects of norepinephrine at the alpha and beta receptors throughout the SNS
- Prevents norepinephrine from activating the receptor lower blood pressure, slower pulse, and increased renal perfusion

Indications:
Htsn, arrhythmia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

CI to Nonselective adrenergic blockers

A

Bradycardia/heart block/HF
DM
Bronchospasm/asthma
Pregnancy / Lactation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

AE to Nonselective blockers

A

CNS – dizziness, paresthesia, insomnia, depression, fatigue, vertigo
GI – n/v/d, anorexia
Card – arrhythmia, hypotension, HF, pulmonary edema, CVA
Resp – bronchospasm, cough, rhinitis
Lab – hypoglycemia, hepatic injury

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

DDI to nonselective blockers

A

Antidiabetic agents
CCBs
QT prolonging antiarrhythmics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Nonselective alpha adrenergic blocker
MED

A

Phentolamine (Reitine, Oraverse) :
- Prevention of cell death/tissue sloughing after extravasation of NE, dopamine
- Prevention of severe HTN during pheochromocytoma surgery
- Reversal of anesthesia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

MOA of Phentolamine

A
  • Blocks postsynaptic alpha1 adrenergic receptors (Decreased sympathetic tone in vasculature :Vasodilation)
  • Blocks presynaptic alpha2 receptors (Prevents feedback NE release : Increase in reflex tachy d/t hypotension_
  • Local vasodilation and return of blood to site of injection
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Indications, CI, AE of Phentolamine

A

Indications:
Htsn, prevention of cell death

CI:
CAD/MI
Preg/lact

AE:
Extension of therapeutic effects
CV – hypotension, angina, MI, flushing, tachycardia, arrhythmia, CVA
CNS – h/a, weakness, dizziness
GI - n/v/d

22
Q

DDI to nonselective alpha blockers

A

Ephedrine/epinephrine
EtOH

23
Q

Alpha 1- selective antagonists

A

Doxazosin: BPH, htsn
Prazosin : htsn
Terazosin: BPH, htsn
Tamsulosin/Alfuzosin: BPH
Silodosin: BPH

PROTOTYPE: Doxazosin
Sexual dysfunction

24
Q

MOA alpha 1 antagonists

A

Block the postsynaptic alpha 1- receptor sites
decrease in vascular tone and vasodilation = decrease BP
Block the smooth muscle receptors in the prostate and urinary bladder
relaxation of bladder and prostate, improved flow of urine

25
Indications, CI, AE of alpha 1 antagonists
Indications: BPH and htsn CI: CHF / renal failure Pregnancy / lactation AE: CNS – h/a, dizziness, weakness, fatigue, depression GI – n/v/d, abdominal pain GU – retrograde ejaculation, priapism CV - arrhythmias, hypotension, edema, CHF, and angina URT – rhinitis, nasal congestion
26
DDI to alpha 2 antagonists
Vasodilators or antihypertensive drugs PDE-4 inhibitors
27
Nonselective beta antagonists MEDS and prototype
Propranolol: HTN, angina, reinfarct after MI, migraine, stress reaction, tremors Nadolol: htsn, angina Nebivolol: htsn Sotalol: ventricular arrhythmia, Afib/flutter Timolol: HTN, reinfarct after MI, migraine, open-angle glaucoma Levobunolol: open angle glaucoma PROTOTYPE: Propranolol
28
MOA Nonselective beta antagonists
- Competitive blocking of the beta-receptors in the SNS - Decrease heart rate Decrease myocardial contractility & rate of conduction, decrease cardiac workload - Block of beta receptors in the heart and in the juxtaglomerular apparatus of the nephron
29
CI to nonselective beta antagonists
- Bradycardia/heart block, HF - Bronchospasm/asthma - Pregnancy / lactation - DM
30
AE to nonselective beta antagonists
CNS – h/a, fatigue, dizziness, depression, sleep disturbances, memory loss, disorientation CV - bradycardia, heart block, orthostatic hypotension, HF, hypotension, peripheral vascular insufficiency Pulm - bronchospasm, pulmonary edema, dyspnea, coughing GI – n/v/d, stomach upset GU - decrease libido, impotence Decreased exercise tolerance
31
DDI to nonselective antagonists
CCB, NSAIDs, ergot alkaloids, antidiabetic agents
32
Beta 1 selective antagonists MEDS and prototype
Metoprolol: htsn, reinfarct after MI, HF Atenolol: MI, angina, htsn Bisoprolol: htsn Esmolol HCL: SVT, afib/flutter PROTOTYPE: Atenolol
33
MOA and indications of beta 1 selective antagonists
MOA: Selectively block beta 1 receptors in the SNS Indications: Hypertension, angina, some cardiac arrhythmias
34
CI to beta 1 selective antagonists
DM, thyroid dz, COPD Bradycardia, heart block, cardiogenic shock, HF, hypotension Pregnancy / lactation
35
AE to beta 1 selective antagonists
CNS – h/a, fatigue, dizziness, paresthesia, depression, sleep disturbances, memory loss, disorientation CV - bradycardia, heart block, HF, hypotension, peripheral vascular insufficiency Pulm - bronchospasm, rhinitis, dyspnea, coughing GI – n/v/d, stomach upset GU - decrease libido, impotence Decreased exercise tolerance
36
DDI to beta 1 selective antagonists
NSAIDs/rifampin/barbiturates CCB, H2, thyroid suppressing
37
Direct-Acting Cholinergic Agonists (Muscarinic) MEDS and prototype
Bethanechol: Treat postop or postpartum urinary retention; neurogenic bladder atony. Diagnose and treat reflux esophagitis Carbachol: Induce miosis or pupil constriction. Relieve intraocular pressure of glaucoma. Perform certain surgical procedures Cevimeline/Pilocarpine: Used to treat symptoms of dry mouth in pt with Sjogren’s syndrome. Reduce IOP in angle-closure glaucoma. Induce miosis PROTOTYPE: Bethanechol
38
MOA to Direct-Acting Cholinergic Agonist (Muscarinic)
- Act at cholinergic receptors in the peripheral nervous system to mimic the effects of ACh and parasympathetic stimulation - Increase contraction of the detrusor muscle of the bladder and relaxes the bladder sphincter - To induce miosis
39
CI Direct-Acting Cholinergic Agonists (Muscarinic)
Any condition that would be exacerbated by parasympathetic effects--bradycardia, hypotension, CAD Peptic ulcer disease, intestinal obst, recent GI surgery Asthma Bladder obstruction Epilepsy and parkinsonism
40
AE and DDI to Direct-Acting Cholinergic Agonists (muscarinic)
AE: CV – bradycardia, heart block, hypotension GI – n/v/d, increased salivation, involuntary defecation, swallowing issues GU – urgency CNS – flushing, sweating DDI: ACh inhibitors
41
Direct-Acting Cholinergic Agonists (Nicotinic) MEDS
Bupropion: smoking cessation Nicotine (habitrol, nicoderm, nicotrol): smoking cessation Varenicline: smoking cessation
42
MOA, CI and indications of Direct-Acting Cholinergic Agonists (Nicotinic)
MOA: Act at nicotinic cholinergic receptors Inhibit reuptake of NE, dopamine Chantix stimulates nicotinic receptors and blocks nicotine from activating receptors Indications: smoking cessation CI: Bupropion - sz
43
AE and DDI Direct-Acting Cholinergic Agonists (Nicotinic)
AE: CV – tachycardia, HTN CNS – (bupropion/varenicline) – depression, mania, agitation, anxiety, paranoia, hallucinations, delusions, dizziness GI – n, dry mouth DDI: Bupropion – MAOI, SNRI, SSRI, BB
44
Indirect-Acting Cholinergic Agonists MOA and indications
- Blocks acetylcholinesterase at the synaptic cleft - allows the accumulation of ACh released from the nerve endings and leads to increased and prolonged stimulation of ACh. Indications: MG and Alzheimer’s
45
CI and AE of Indirect-Acting Cholinergic Agonists
CI: Bradycardia, intestinal/urinary tract obs Any condition exacerbated by cholinergic stimulation Asthma, CAD, PUD, arrhythmia, sz, parkinsonism AE: CV – bradycardia, heart block, hypotension GI – n/v/d, increased salivation, involuntary defecation GU – urgency CNS – flushing, sweating, miosis, blurred vision, h/a, dizziness
46
DDI to Indirect-Acting Cholinergic Agonists
DDI: NSAIDS
47
MEDS to tx MG and prototype
neostigmine: Has a strong influence at the neuromuscular junction (Antidote : pralidoxime available as an auto injection to military personnel at risk) pyridostigmine : Has a longer duration of action than neostigmine (can be given IV for patients who can’t swallow) edrophonium: Diagnostic agent for myasthenia gravis (short-acting) PROTOTYPE: pyridostigmine
48
MEDS to tx alzheimers and prototype
Galantamine: stops progression Rivastigmine Donepezil: once a day dosing PROTOTYPE: Donepezil Atropine antidote for Indirect-Acting Cholinergic Agonists
49
Anti- Cholinergic (atropine) MOA and indications
MOA: Used to block the effects of acetylcholine block effects of the PNS; also called parasympatholytic agents Indications: Decrease GI activity and secretions (treat ulcers) Bronchospasm/COPD OAB, incontinence, neurogenic bladder IBS, PUD, n/v
50
CI to anticholinergic
Glaucoma Stenosing PUD, paralytic ileus, GI obs, ulcerative colitis BPH, bladder obs MG Arrhythmia, tachycardia ischemia
51
AE and DDI to anti- cholinergics
AE: CNS – blurred vision, pupil dilation, photophobia, cycloplegia, increased IOP, weakness, dizziness, insomnia, psychosis, decreased sweating, heat prostration GI – dry mouth, b/c, heartburn CV – tachycardia, palpitations GU – hesitancy, retention DDI: Other drugs with anticholinergic properties